Detalhe da pesquisa
1.
HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia.
Eur J Haematol
; 112(3): 392-401, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37933194
2.
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.
Blood
; 135(19): 1696-1703, 2020 05 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32107559
3.
Relating NF-κB regulation to MPN pathogenesis.
Blood
; 143(23): 2345-2347, 2024 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38842861
4.
Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms.
J Theor Biol
; 425: 43-52, 2017 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-28501635
5.
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
N Engl J Med
; 368(19): 1781-90, 2013 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-23656643
6.
BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.
Blood
; 124(22): 3260-73, 2014 Nov 20.
Artigo
Inglês
| MEDLINE | ID: mdl-25293778
7.
The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
Blood
; 122(22): 3628-31, 2013 Nov 21.
Artigo
Inglês
| MEDLINE | ID: mdl-24081659
8.
Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm.
Mediators Inflamm
; 2015: 606819, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26538830
9.
ALDH marks leukemia stem cell.
Blood
; 119(15): 3376-7, 2012 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-22500050
10.
JAK2 V617F down-modulates MPL.
Blood
; 119(20): 4579-80, 2012 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-22596167
11.
Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML.
Blood
; 120(13): 2658-68, 2012 Sep 27.
Artigo
Inglês
| MEDLINE | ID: mdl-22889761
12.
Hematopoietic stem cell transplantation for myelofibrosis: where are we now?
Curr Opin Hematol
; 20(2): 130-6, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23314844
13.
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence.
Cancer Res Commun
; 4(3): 660-670, 2024 03 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38391189
14.
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.
Blood
; 118(24): 6392-8, 2011 Dec 08.
Artigo
Inglês
| MEDLINE | ID: mdl-21860020
15.
Myeloproliferative neoplasms - blurring the lines between cancer and chronic inflammatory disorder.
Front Oncol
; 13: 1208089, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37361587
16.
Characterizing the microbiome of patients with myeloproliferative neoplasms during a Mediterranean diet intervention.
mBio
; : e0230823, 2023 Oct 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37877698
17.
Cigarette smoke stimulates clonal expansion of Jak2V617F and Tet2-/- cells.
Front Oncol
; 13: 1210528, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37546389
18.
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase.
medRxiv
; 2023 May 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37214789
19.
Fecal Microbial Community Composition in Myeloproliferative Neoplasm Patients Is Associated with an Inflammatory State.
Microbiol Spectr
; 10(3): e0003222, 2022 06 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35475626
20.
The Microenvironment in Myeloproliferative Neoplasms.
Hematol Oncol Clin North Am
; 35(2): 205-216, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33641864